Chemours vs Perimeter
CC and PRM side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CC and PRM compare
Perimeter is the larger company, worth 2.4 times as much as Chemours ($5.0B against $2.1B).
Perimeter grew revenue faster over the last twelve months (30.7% versus 0.07% for Chemours).
Perimeter keeps more of each dollar of sales as profit, with a net margin of 6.7% compared with −2.6% at Chemours.
Chemours pays a dividend yielding 2.6%; Perimeter does not pay one.
Perimeter scores higher on the StockData Score (7 against 5 for Chemours), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CC | PRM |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $5.0B |
| Share price | $13.72 | $30.67 |
| Change, 1 year | 7.6% | 19.7% |
| Change, 5 years | −56.8% | 138% |
| Beta (5Y) | 1.57 | 1.22 |
| Employees | 5,700 | 356 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | – | 170× |
| P/S | 0.4× (better) | 6.0× |
| P/B | 13.3× | 3.8× (better) |
| EV/EBITDA | 7.2× (better) | 26.9× |
| P/FCF | 9.8× (better) | 93.1× |
| FCF yield | 10.2% (better) | 1.1% |
| Fair value | – | $9.21 |
| Margin of safety | – | −233% |
| Growth | ||
| Revenue growth (TTM) | 0.07% | 30.7% (better) |
| Revenue growth, 5Y average | 3.2% | 14.0% (better) |
| Net income growth (TTM) | – | −28.8% |
| EPS growth (TTM) | – | −64.0% |
| Profitability | ||
| Gross margin | 15.2% | 54.5% (better) |
| Operating margin | – | 14.5% |
| Net margin | −2.6% | 6.7% (better) |
| FCF margin | 3.6% | 6.5% (better) |
| Return on equity | −71.8% | 4.6% (better) |
| Return on invested capital | – | 6.3% |
| Financial health | ||
| Debt / equity | 24.73 | 0.91 (better) |
| Net debt / EBITDA | 4.32 (better) | 4.82 |
| Interest coverage | – | 1.6× |
| Current ratio | 1.81 | 2.79 (better) |
| Altman Z-score | 1.42 | 1.70 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.6% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | −12.5% | – |
| Buyback yield | – | 0.00% |
| Shareholder yield | 2.6% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 90.2% | 85.6% |
| Held by insiders | 0.96% | 22.6% |
| Insider net buying, 12 months | $489K (better) | −$435M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 9.8% | 5.2% |
Go deeper
- CC stock overview
- CC income statement
- CC valuation and score
- PRM stock overview
- PRM income statement
- PRM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.